Amazon´s On Demand Textiles Manufacturing
A US patent for on demand textiles manufacturing has been granted to the e-commerce giant Amazon. Can it redefine fast-fashion?
Real business category in stepchange innovations blog
A US patent for on demand textiles manufacturing has been granted to the e-commerce giant Amazon. Can it redefine fast-fashion?
Financial investors are taking more interest in the textile printing and digital printing space. Investcorp has announced the acquisition of SPGPrints Group. SPGPrints, a Dutch company formerly known as Stork Prints, is a leading supplier of printing systems and consumables for textile printing.
GlaxoSmithKline and Save the Children have launched a fund totalling $1,000,000 to reward organisations practicing innovative approaches for reducing under-5 child mortality.
Open innovation is today a modern management tool within corporate innovation management - in the last decade open innovation has become an important extension to the classical innovation approach, to improve the success rate of the innovation pipeline.
In 2012 and Q1 2013, mergers and acquisitions (M&A) activity in the chemical industry was low. Now, according to consensus view of the world´s leading consultancy firms, M&A activities in the chemical industry are expected to take off.
The Indian Supreme court has rejected a key patent of Novartis for their cancer drug Glivec. The verdict adds to a series of strikes against multinational pharmaceutical companies to gain patent rights in India, potentially one of the biggest pharmaceutical markets in the world.
In this article we discuss CRO offshore outsourcing in the chemical and pharmaceutical industry, especially what drives outsourcing, the process for vendor selection, typical problems in CRO outsouring, and CRO Offshore Outsourcing to China and India.
We will outline in the second part of this article series how big is the business of Contract research and manufacturing services (CRAMS) in the pharmaceutical, bio-technological and chemical industry.
Contract research and manufacturing services (CRAMS) in the pharmaceutical, bio-technological and chemical industry is massive, a multi-billion dollar business. We will outline in this article how big is this business, what drives this business and what are the implications for enterprises and for the society ? We will outline in this article the political and macro-economical implications of outsourcing.